Predict your next investment

Asset/Investment Management
firstred.com

See what CB Insights has to offer

Investments

24

Portfolio Exits

1

Funds

1

About Firstred Capital

Firstred Capital is a private equity and venture capital fund manager.

Firstred Capital Headquarter Location

5th Floor, North Building, No. 3, No. 5, Jinshifang Street, Xicheng District

Beijing, Beijing,

China

+86(10) 5927 2260

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Firstred Capital News

Allorion Therapeutics Completes $40M Series A Financing Round

Nov 24, 2021

Allorion Therapeutics , a Boston, MA-based next-generation precision medicine company focused on oncology and autoimmune diseases, compled a $40M Series A financing. This round was led by Qiming Venture Partners with participation from IDG Capital, Octagon Capital, Firstred Capital, and Elikon Venture, as well as existing investors TF Capital and Med-Fine Capital. The company intends to use the funds to accelerate the advancement of preclinical projects, IND-enabling studies and IND applications of two drug candidates in China and the United States, to increase its investment in its platform technologies in the systematic screen for allosteric inhibitors and synthetic lethality targets with matching tool compounds, and to enhance the clinical and business development teams. Led by Peter Ding, Founder and CEO, Allorion leverages a drug discovery engine which integrates technological breakthroughs in protein structure, big data, machine learning and gene editing to systematically discover and develop highly selective small molecules, including covalent and allosteric inhibitors of well-validated targets. The company has also built a synthetic lethality screening platform to expand the scope of targeted therapies for cancer patients, laying a solid foundation for its long-term success. FinSMEs 24/11/2021

Firstred Capital Investments

24 Investments

Firstred Capital has made 24 investments. Their latest investment was in Ruichen Pet as part of their Seed on May 5, 2022.

CBI Logo

Firstred Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/10/2022

Seed

Ruichen Pet

Yes

2

5/5/2022

Seed

Sectrend

Yes

3

4/24/2022

Series C

Worktile

$15.25M

Yes

3

2/17/2022

Series A

Subscribe to see more

Subscribe to see more

10

12/23/2021

Series B

Subscribe to see more

Subscribe to see more

10

Date

5/10/2022

5/5/2022

4/24/2022

2/17/2022

12/23/2021

Round

Seed

Seed

Series C

Series A

Series B

Company

Ruichen Pet

Sectrend

Worktile

Subscribe to see more

Subscribe to see more

Amount

$15.25M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

3

10

10

Firstred Capital Portfolio Exits

1 Portfolio Exit

Firstred Capital has 1 portfolio exit. Their latest portfolio exit was Hualan Biological Bacterin on February 18, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/18/2022

IPO

$99M

1

Date

2/18/2022

Exit

IPO

Companies

Valuation

$99M

Acquirer

Sources

1

Firstred Capital Acquisitions

1 Acquisition

Firstred Capital acquired 1 company. Their latest acquisition was Yuga Group on June 01, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/1/2021

$99M

Acq - Fin

1

Date

6/1/2021

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acq - Fin

Sources

1

Firstred Capital Fund History

1 Fund History

Firstred Capital has 1 fund, including 人民幣併購基金 (RMB M&A Fund I).

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/7/2021

人民幣併購基金 (RMB M&A Fund I)

$1,050.23M

8

Closing Date

1/7/2021

Fund

人民幣併購基金 (RMB M&A Fund I)

Fund Type

Status

Amount

$1,050.23M

Sources

8

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.